logo
logo

Bioinnovation Institute Launches Venture Lab Program With Intake Of Innovative Early-Stage Companies

Sep 14, 2021•almost 4 years ago
Copenhagen

Description

BioInnovation Institute (BII), an international commercial foundation with a non-profit objective incubating and accelerating world-class life science research, today announces the first cohort of participants in the Venture Lab acceleration program for early-stage companies. Comprising a pan-European spread of start-up initiatives and university research projects, the seven ventures are developing revolutionary science across BII's three sector specialised areas – therapeutics, bioindustrials and health tech.

Company Information

Company

The Bio Innovation Institute Foundation

Location

Copenhagen, Capital Region Of Denmark, Denmark

About

The BioInnovation Institute Foundation (BII) is an international commercial foundation with a nonprofit objective supported by the Novo Nordisk Foundation. BII operates an incubator to accelerate world-class life science innovation that drives the development of new solutions by early life science start-ups for the benefit of people and society. BII, located in Copenhagen, Denmark, offers start-ups and early-stage projects within health tech, therapeutics, and bioindustrials state-of-the-art labs, vibrant office facilities, business development, start-up business incubation, access to high-level mentoring and international networks, plus unique funding opportunities of up to 1.3 million euro per start-up and 2.4 million euro per project. Since the inauguration of BII in November 2018, BII has awarded 35 million euros to 68 high-growth start-up companies. Read more on www.bioinnovationinstitute.com SOURCE BII